The government's move toward a fair-equals-cheap model of drug pricing may have long-term implications for patients and our health-care system.
The prime minister and his health minister, Ginette Petitpas Taylor, pictured speaking to reporters Dec. 5 in the House foyer after Question Period, ought to reconsider their recent stance on drug pricing, writes Life Sciences Ontario chief Jason Field. The Hill Times photograph by Andrew Meade
Earlier this month, the Patented Medicine Prices Review Board published new regulations that could see drug prices cut by up to 20 per cent.
People. Policy. Politics. This is an exclusive subscriber-only story.
'Building diverse and inclusive workforces is essential to the effectiveness of the security and intelligence community,' according to the National Security and Intelligence Committee of Parliamentarians' annual report.
Justin Trudeau's Liberals should ensure they don’t end up in anymore ethical controversies, as these scandals lead people to think that it is ‘time for change,’ says Innovative Research president Greg Lyle.
'My primary concern was to make sure that the public service could fully support its recommendation, that without a doubt, WE Charity was the right, and indeed, the only partner to deliver the program,' says Mr. Trudeau.
'Canada is proud of being an independent country, or a country with its own independent foreign policy, so I hope that Canada is wise enough to make its own decision,' says Cong Peiwu, China's ambassador to Canada.